BioCorRx (BICX) Non-Current Deferred Tax Liability (2013 - 2025)
BioCorRx (BICX) posted Non-Current Deferred Tax Liability of $5.3 million for Q2 2025, little changed sequentially from $5.3 million in Q1 2025.
BioCorRx (BICX) Non-Current Deferred Tax Liability (2013 - 2025) Analysis & Trends
BioCorRx has reported Non-Current Deferred Tax Liability for 11 years, with the latest figure at $5.3 million in Q2 2025.
- Quarterly Non-Current Deferred Tax Liability changed N/A year-over-year to $5.3 million in Q2 2025, while the trailing twelve-month figure through Jun 2025 was $5.3 million (changed N/A YoY) and the FY2024 annual result came in at $39349.0, down 80.32% from the prior year.
- Non-Current Deferred Tax Liability was little changed at $5.3 million in Q2 2025 per BICX's latest filing, from $5.3 million in the prior quarter.
- Over five years, Non-Current Deferred Tax Liability peaked at $5.3 million in Q1 2025 and troughed at $39349.0 in Q4 2024.
- A 4-year average of $2.2 million and a median of $361781.0 in 2022 frame the typical range for Non-Current Deferred Tax Liability.
- The sharpest annual moves came in 2023 and 2024: Non-Current Deferred Tax Liability slumped 44.73% in 2023, then sank 80.32% in 2024.
- Over 4 years, Non-Current Deferred Tax Liability stood at $361781.0 in 2022, then sank by 44.73% to $199952.0 in 2023, then tumbled by 80.32% to $39349.0 in 2024, then surged by 13388.07% to $5.3 million in 2025.
- According to Business Quant data, Non-Current Deferred Tax Liability over the past three periods registered $5.3 million, $5.3 million, and $39349.0 for Q2 2025, Q1 2025, and Q4 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | HCA Healthcare | 88.19 Bn | 90.61 Bn | 15.19 Bn |
| 2 | Tenet Healthcare | 21.59 Bn | 21.56 Bn | 4.45 Bn |
| 3 | Encompass Health | 12.19 Bn | 12.86 Bn | 1.34 Bn |
| 4 | Davita | 11.52 Bn | 12.39 Bn | 1.16 Bn |
| 5 | Ensign | 10.59 Bn | 10.27 Bn | 306.24 Mn |
| 6 | Universal Health Services | 8.79 Bn | 8.72 Bn | 3.29 Bn |
| 7 | Pacs | 7.04 Bn | 6.88 Bn | 338.46 Mn |
| 8 | Chemed | 6.96 Bn | 6.92 Bn | 221.47 Mn |
| 9 | Concentra Group Holdings Parent | 4.52 Bn | 4.38 Bn | 192.10 Mn |
| 10 | BioCorRx | 1.49 Mn | 1.47 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 5.31 Mn |
| Jun 30, 2025 | 5.31 Mn |
| Mar 31, 2025 | 5.31 Mn |
| Mar 31, 2025 | 5.31 Mn |
| Dec 31, 2024 | 39,349.00 |
| Dec 31, 2024 | 39,349.00 |
| Dec 31, 2023 | 199,952.00 |
| Dec 31, 2023 | 199,952.00 |
| Dec 31, 2022 | 361,781.00 |
| Dec 31, 2022 | 361,781.00 |
| Dec 31, 2020 | 573,541.00 |
| Dec 31, 2020 | 573,541.00 |
| Dec 31, 2019 | -42,915.00 |
| Dec 31, 2019 | -42,915.00 |
| Dec 31, 2017 | 56,600.00 |
| Dec 31, 2017 | 56,600.00 |
| Dec 31, 2016 | 56,600.00 |
| Dec 31, 2016 | 56,600.00 |
| Dec 31, 2015 | 56,600.00 |
| Dec 31, 2015 | 56,600.00 |